Bajaj Finserv Healthcare Fund holds 35 instruments (96.58% equity), led by Divi's Laboratories Limited (9.67%), Sun Pharmaceutical Industries Limited (8.87%) and Piramal Pharma Limited (6.6%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Bajaj Finserv Healthcare Fund, managed by Bajaj Finserv Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 35 instruments with an equity allocation of 96.58%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Bajaj Finserv Healthcare Fund's top 10 holdings account for 61.85% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 87.6% of net assets, spread across 6 sectors in total. Since its 30 June 2026 disclosure, the fund added 3 new positions and exited 4 positions, with Sun Pharmaceutical Industries Limited seeing the largest move (+2.51pp to 8.87%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 6.36% → 8.87% | ▲ +2.51 |
| Divi's Laboratories Limited | 8.4% → 9.67% | ▲ +1.27 |
| Piramal Pharma Limited | 6.04% → 6.6% | ▲ +0.56 |
| Laurus Labs Limited | 2.14% → 2.41% | ▲ +0.27 |
| Torrent Pharmaceuticals Limited | 5.26% → 5.48% | ▲ +0.22 |
| Dr. Lal Path Labs Ltd. | 1.64% → 1.78% | ▲ +0.14 |
| Stock | Weight | Change |
|---|---|---|
| Aurobindo Pharma Limited | 6.52% → 6.13% | ▼ -0.39 |
| Max Healthcare Institute Limited | 4.16% → 3.8% | ▼ -0.36 |
| Fortis Healthcare Limited | 3.25% → 3.01% | ▼ -0.24 |
| Apollo Hospitals Enterprise Limited | 6.71% → 6.5% | ▼ -0.21 |
| Senores Pharmaceuticals Limited | 2.29% → 2.11% | ▼ -0.18 |
| TURTLEMINT FINTECH SOLUTIONS | 1% → 0.83% | ▼ -0.17 |
| Neuland Laboratories Limited | 4.59% → 4.42% | ▼ -0.17 |
| Zydus Wellness Limited | 2.82% → 2.66% | ▼ -0.16 |
| Navin Fluorine International Limited | 2.17% → 2.01% | ▼ -0.16 |
| Vijaya Diagnostic Centre Limited | 2.36% → 2.2% | ▼ -0.16 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Bajaj Finserv Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.